Australian Minister for Health announced PBS listing of Buvidal® Weekly and Monthly for treatment of opioid dependence
- The Australian Government invests $40 million to provide patients affordable access to two new medicine listings through the Pharmaceutical Benefit Scheme (PBS) Lund, Sweden — 26 August 2019 — The Australian Federal Health Minister Greg Hunt announced on Sunday that Camurus’ long-acting medication Buvidal® Weekly and Monthly (buprenorphine) solutions for injection will be listed on the PBS. From September, Buvidal® will be fully subsidised as a part of a $40 million investment by the Australian Govenment.[1,2] Over 110,000 Australians are currently struggling with opioid